The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Gene-specific requirement for P-TEFb activity and RNA polymerase II phosphorylation within the p53 transcriptional program
Open accessAbstract
Activation of the p53 pathway mediates cellular responses to diverse forms of stress. Here we report that the p53 target gene p21 CIP1 is regulated by stress at post-initiation steps through conversion of paused RNA polymerase II (RNAP II) into an elongating form. High-resolution chromatin immunoprecipitation assays (ChIP) demonstrate that p53-dependent activation of p21 CIP1 transcription after DNA damage occurs concomitantly with changes in RNAP II phosphorylation status and recruitment of the elongation factors DSIF (DRB Sensitivity-Inducing Factor), P-TEFb (Positive Transcription Elongation Factor b), TFIIH, TFIIF, and FACT (Facilitates Chromatin Transcription) to distinct regions of the p21 CIP1 locus. Paradoxically, pharmacological inhibition of P-TEFb leads to global inhibition of mRNA synthesis but activation of the p53 pathway through p53 accumulation, expression of specific p53 target genes, and p53-dependent apoptosis. ChIP analyses of p21 CIP1 activation in the absence of functional P-TEFb reveals the existence of two distinct kinases that phosphorylate Ser5 of the RNAP II C-terminal domain (CTD). Importantly, CTD phosphorylation at Ser2 is not required for p21 CIP1 transcription, mRNA cleavage, or polyadenylation. Furthermore, recruitment of FACT requires CTD kinases, yet FACT is dispensable for p21 CIP1 expression. Thus, select genes within the p53 pathway bypass the requirement for P-TEFb and RNAP II phosphorylation to trigger a cellular response to inhibition of global mRNA synthesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
Vogelstein, B., Lane, D., & Levine, A. J. (2000) · Nature · doi:10.1038/35042675 · Cited by 6,607 · cited 2×
“…a selective pressure to inactivate this protein during tumor growth, and as a result p53 is the most commonly mutated tumor suppressor gene (Vogelstein et al. 2000; Vousden 2002). p53 is a sequence-specific DNA-binding protein that functions primarily as a transcriptional regulator (Kern…”
BackgroundLive or let die: the cell's response to p53
Vousden, K. H., & Lu, X. (2002) · Nature Reviews Cancer · doi:10.1038/nrc864 · Cited by 3,192
Requirement for p53 and p21 to Sustain G 2 Arrest After DNA Damage
Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J. P., Sedivy, J. M., Kinzler, K. W., & Vogelstein, B. (1998) · Science · doi:10.1126/science.282.5393.1497 · Cited by 2,803
Komarnitsky, P., Cho, E.-J., & Buratowski, S. (2000) · Genes & Development · doi:10.1101/gad.824700 · Cited by 1,095
Identification of p53 as a Sequence-Specific DNA-Binding Protein
Kern, S. E., Kinzler, K. W., Bruskin, A., Jarosz, D., Friedman, P., Prives, C., & Vogelstein, B. (1991) · Science · doi:10.1126/science.2047879 · Cited by 1,085
Integrating mRNA Processing with Transcription
Proudfoot, N. J., Furger, A., & Dye, M. J. (2002) · Cell · doi:10.1016/s0092-8674(02)00617-7 · Cited by 1,082
Yamaguchi, Y., Takagi, T., Wada, T., Yano, K., Furuya, A., Sugimoto, S., Hasegawa, J., & Handa, H. (1999) · Cell · doi:10.1016/s0092-8674(00)80713-8 · Cited by 841
Elongation by RNA polymerase II: the short and long of it
Sims, R. J., Belotserkovskaya, R., & Reinberg, D. (2004) · Genes & Development · doi:10.1101/gad.1235904 · Cited by 709
Transcription elongation factor P-TEFb is required for HIV-1 Tat transactivation in vitro
Zhu, Y., Pe’ery, T., Peng, J., Ramanathan, Y., Marshall, N., Marshall, T., Amendt, B., Mathews, M. B., & Price, D. H. (1997) · Genes & Development · doi:10.1101/gad.11.20.2622 · Cited by 696
P-TEFb, a Cyclin-Dependent Kinase Controlling Elongation by RNA Polymerase II
Price, D. H. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.8.2629-2634.2000 · Cited by 679
NPAT links cyclin E–Cdk2 to the regulation of replication-dependent histone gene transcription
Zhao, J., Kennedy, B. K., Lawrence, B. D., Barbie, D. A., Matera, A. G., Fletcher, J. A., & Harlow, E. (2000) · Genes & Development · doi:10.1101/gad.827700 · Cited by 665
Control of RNA Polymerase II Elongation Potential by a Novel Carboxyl-terminal Domain Kinase
Marshall, N. F., Peng, J., Xie, Z., & Price, D. H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.43.27176 · Cited by 662 · cited 3×
“The occupancy pattern of DRB-insensitive Ser5 phosphorylation matches that of CDK7, the kinase subunit of TFIIH that is known to be less sensitive to DRB (Marshall et al. 1996).”
BackgroundAnalysis of p53-regulated gene expression patterns using oligonucleotide arrays
Zhao, R., Gish, K., Murphy, M., Yin, Y., Notterman, D., Hoffman, W. H., Tom, E., Mack, D. H., & Levine, A. J. (2000) · Genes & Development · doi:10.1101/gad.14.8.981 · Cited by 634
Flavopiridol Inactivates P-TEFb and Blocks Most RNA Polymerase II Transcription in Vivo
Chao, S.-H., & Price, D. H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102306200 · Cited by 621
Wild-type p53 activates transcription in vitro
Farmer, G., Bargonetti, J., Zhu, H., Friedman, P., Prywes, R., & Prives, C. (1992) · Nature · doi:10.1038/358083a0 · Cited by 579 · cited 2×
“…during tumor growth, and as a result p53 is the most commonly mutated tumor suppressor gene (Vogelstein et al. 2000; Vousden 2002). p53 is a sequence-specific DNA-binding protein that functions primarily as a transcriptional regulator (Kern et al. 1991; Farmer et al. 1992; Zhao et al. 2000).”
BackgroundRNA polymerase II and the integration of nuclear events
Hirose, Y., & Manley, J. L. (2000) · Genes & Development · doi:10.1101/gad.14.12.1415 · Cited by 575
The chromatin-specific transcription elongation factor FACT comprises human SPT16 and SSRP1 proteins
Orphanides, G., Wu, W.-H., Lane, W. S., Hampsey, M., & Reinberg, D. (1999) · Nature · doi:10.1038/22350 · Cited by 554
PUMA Couples the Nuclear and Cytoplasmic Proapoptotic Function of p53
Chipuk, J. E., Bouchier-Hayes, L., Kuwana, T., Newmeyer, D. D., & Green, D. R. (2005) · Science · doi:10.1126/science.1114297 · Cited by 546
Ahn, S. H., Kim, M., & Buratowski, S. (2004) · Molecular Cell · doi:10.1016/s1097-2765(03)00492-1 · Cited by 516
Kizer, K. O., Phatnani, H. P., Shibata, Y., Hall, H., Greenleaf, A. L., & Strahl, B. D. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.8.3305-3316.2005 · Cited by 511
Rules of engagement: co-transcriptional recruitment of pre-mRNA processing factors
Bentley, D. L. (2005) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2005.04.006 · Cited by 486
Wang, Q., Carroll, J. S., & Brown, M. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.07.018 · Cited by 450
Cho, E.-J., Kobor, M. S., Kim, M., Greenblatt, J., & Buratowski, S. (2001) · Genes & Development · doi:10.1101/gad.935901 · Cited by 428
Lam, L. T., Pickeral, O. K., Peng, A. C., Rosenwald, A., Hurt, E. M., Giltnane, J. M., Averett, L. M., Zhao, H., Davis, R. E., Sathyamoorthy, M., et al. (2001) · Genome Biology · doi:10.1186/gb-2001-2-10-research0041 · Cited by 370
Wada, T. (1998) · The EMBO Journal · doi:10.1093/emboj/17.24.7395 · Cited by 354
Ho, C. K., & Shuman, S. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80468-2 · Cited by 338
Histone H2B Ubiquitylation Is Associated with Elongating RNA Polymerase II
Xiao, T., Kao, C.-F., Krogan, N. J., Sun, Z.-W., Greenblatt, J. F., Osley, M. A., & Strahl, B. D. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.2.637-651.2005 · Cited by 338
Activation of the p53 tumor suppressor protein
Vousden, K. H. (2002) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(02)00035-5 · Cited by 337
Recycling of the general transcription factors during RNA polymerase II transcription.
Zawel, L., Kumar, K. P., & Reinberg, D. (1995) · Genes & Development · doi:10.1101/gad.9.12.1479 · Cited by 320
Cytoplasmic Polyadenylation in Development and Beyond
Richter, J. D. (1999) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.63.2.446-456.1999 · Cited by 299
Transitions in RNA polymerase II elongation complexes at the 3′ ends of genes
Kim, M., Ahn, S., Krogan, N. J., Greenblatt, J. F., & Buratowski, S. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600053 · Cited by 291
Inhibition of RNA polymerase II as a trigger for the p53 response
Ljungman, M., Zhang, F., Chen, F., Rainbow, A. J., & McKay, B. C. (1999) · Oncogene · doi:10.1038/sj.onc.1202356 · Cited by 288
Espinosa, J. M., Verdun, R. E., & Emerson, B. M. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00359-9 · Cited by 256
Self-citationSsu72 Is an RNA Polymerase II CTD Phosphatase
Krishnamurthy, S., He, X., Reyes-Reyes, M., Moore, C. L., & Hampsey, M. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00235-7 · Cited by 255
Coordination of Transcription, RNA Processing, and Surveillance by P-TEFb Kinase on Heat Shock Genes
Ni, Z., Schwartz, B. E., Werner, J., Suarez, J.-R., & Lis, J. T. (2004) · Molecular Cell · doi:10.1016/s1097-2765(03)00526-4 · Cited by 240
Dynamics of Enhancer-Promoter Communication during Differentiation-Induced Gene Activation
Hatzis, P., & Talianidis, I. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00786-4 · Cited by 228
Luecke, H. F., & Yamamoto, K. R. (2005) · Genes & Development · doi:10.1101/gad.1297105 · Cited by 217
Yeo, M., Lin, P. S., Dahmus, M. E., & Gill, G. N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301791200 · Cited by 212
Shim, E. Y., Walker, A. K., Shi, Y., & Blackwell, T. K. (2002) · Genes & Development · doi:10.1101/gad.999002 · Cited by 194
Regulation of transcription elongation by phosphorylation
Kobor, M. S., & Greenblatt, J. (2002) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(02)00457-8 · Cited by 187
Transcriptional Elongation by RNA Polymerase II and Histone Methylation
Gerber, M., & Shilatifard, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.r300014200 · Cited by 168
Cyclin-dependent kinase inhibitors
Dai, Y. (2003) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(03)00079-1 · Cited by 163
Garber, M. E., Mayall, T. P., Suess, E. M., Meisenhelder, J., Thompson, N. E., & Jones, K. A. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.18.6958-6969.2000 · Cited by 162
Bird, G. A., Zorio, D. A. R., & Bentley, D. L. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.20.8963-8969.2004 · Cited by 162
Three RNA Polymerase II Carboxyl-terminal Domain Kinases Display Distinct Substrate Preferences
Ramanathan, Y., Rajpara, S. M., Reza, S. M., Lees, E. M., Shuman, S., Mathews, M. B., & Pe’ery, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010975200 · Cited by 148
Jones, J. C., Phatnani, H. P., Haystead, T., MacDonald, J. A., Alam, S. M., & Greenleaf, A. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402218200 · Cited by 130
Characterization of the Residues Phosphorylated in Vitro by Different C-terminal Domain Kinases
Trigon, S., Serizawa, H., Conaway, J. W., Conaway, R. C., Jackson, S. P., & Morange, M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.12.6769 · Cited by 128
Cyclin C/CDK8 and cyclin H/CDK7/p36 are biochemically distinct CTD kinases
Rickert, P., Corden, J. L., & Lees, E. M. (1999) · Oncogene · doi:10.1038/sj.onc.1202399 · Cited by 122
Erster, S. H., & Moll, U. M. (2004) · Cell Cycle · doi:10.4161/cc.3.12.1318 · Cited by 42
Functional Coupling of Cleavage and Polyadenylation with Transcription of mRNA
Adamson, T. E., Shutt, D. C., & Price, D. H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505532200 · Cited by 42
Cited by
Transcriptional Regulation by P53
Beckerman, R., & Prives, C. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000935 · Cited by 569
Inhibiting eukaryotic transcription: which compound to choose? How to evaluate its activity
Bensaude, O. (2011) · Transcription · doi:10.4161/trns.2.3.16172 · Cited by 574
Blazek, D., Kohoutek, J., Bartholomeeusen, K., Johansen, E., Hulinkova, P., Luo, Z., Cimermancic, P., Ule, J., & Peterlin, B. M. (2011) · Genes & Development · doi:10.1101/gad.16962311 · Cited by 522
Rates of in situ transcription and splicing in large human genes
Singh, J., & Padgett, R. A. (2009) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1666 · Cited by 487
The RNA Polymerase II Carboxy-Terminal Domain (CTD) Code
Eick, D., & Geyer, M. (2013) · Chemical Reviews · doi:10.1021/cr400071f · Cited by 470
Metadata
- Authors
- Gomes, N. P., Bjerke, G., Llorente, B., Szostek, S. A., Emerson, B. M., & Espinosa, J. M.
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2006-03-01
- Volume
- 20
- Issue
- 5
- Pages
- 601-612
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- OpenAlex
- W2136411119
- Cited by
- 266
- References
- 51
- Type
- posted content
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.